Horizon Therapeutics
Horizon Therapeutics[edit | edit source]
Horizon Therapeutics is a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company is headquartered in Dublin, Ireland, with significant operations in the United States.
History[edit | edit source]
Horizon Therapeutics was founded in 2008. Over the years, the company has grown through strategic acquisitions and the development of a robust pipeline of medicines. Horizon has focused on expanding its portfolio to include treatments for rare diseases, which often have limited therapeutic options.
Products[edit | edit source]
Horizon Therapeutics has developed a range of products, primarily targeting rare diseases and conditions related to inflammation and autoimmunity. Some of the key products include:
- Tepezza (teprotumumab-trbw) - A treatment for Thyroid Eye Disease (TED), a rare autoimmune condition.
- Krystexxa (pegloticase) - Used for chronic gout in adult patients who are refractory to conventional therapy.
- Ravicti (glycerol phenylbutyrate) - Indicated for the chronic management of urea cycle disorders.
Research and Development[edit | edit source]
Horizon Therapeutics invests significantly in research and development to discover new therapies and improve existing ones. The company collaborates with academic institutions, research organizations, and other pharmaceutical companies to advance its scientific goals.
Corporate Social Responsibility[edit | edit source]
Horizon is committed to corporate social responsibility, focusing on patient advocacy, community engagement, and environmental sustainability. The company supports various initiatives to improve patient access to medicines and enhance the quality of life for those affected by rare diseases.
Related pages[edit | edit source]
| Pharmaceutical companies | ||||||
|---|---|---|---|---|---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
